Skip to main content

Peer Review reports

From: Clinical outcomes and risk factor of immune checkpoint inhibitors-related pneumonitis in non-small cell lung cancer patients with chronic obstructive pulmonary disease

Original Submission
21 Jul 2022 Submitted Original manuscript
26 Aug 2022 Reviewed Reviewer Report
31 Aug 2022 Reviewed Reviewer Report
19 Sep 2022 Author responded Author comments - Yuehong Wang
Resubmission - Version 2
19 Sep 2022 Submitted Manuscript version 2
24 Sep 2022 Author responded Author comments - Yuehong Wang
Resubmission - Version 3
24 Sep 2022 Submitted Manuscript version 3
Publishing
10 Oct 2022 Editorially accepted
1 Dec 2022 Article published 10.1186/s12890-022-02190-w

You can find further information about peer review here.

Back to article page